Clinical Characteristics and Associations of the "Good Fontan" Patient

Sponsor
Boston Children's Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03470428
Collaborator
New England Congenital Cardiology Association (NECCA) (Other), Yale University (Other), Dartmouth College (Other), Connecticut Children's Medical Center (Other), University of Vermont Children's Hospital (Other), Child Heart Associates (Other), Congenital Heart (Other), University of Massachusetts, Worcester (Other), Massachusetts General Hospital (Other)
200
1
95.9
2.1

Study Details

Study Description

Brief Summary

This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a multi-center prospective study that involves collecting data from patients as well as their cardiology providers in order to determine whether there is correlation between patient-reported quality of life assessments and clinician-identified assessments of their patients. The study also involves collecting data from the medical records of participating patients and entering it into our study database.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Clinical Characteristics and Associations of the "Good Fontan" Patient
    Actual Study Start Date :
    Mar 5, 2018
    Anticipated Primary Completion Date :
    Mar 1, 2024
    Anticipated Study Completion Date :
    Mar 1, 2026

    Arms and Interventions

    Arm Intervention/Treatment
    Pediatric Fontan Patients

    Participants ages 10 to 18 who have had Lateral Tunnel or Extracardiac Fontan procedures.

    Adult Fontan Patients

    Participants ages 18 to 60 who have had Lateral Tunnel or Extracardiac Fontan procedures.

    Outcome Measures

    Primary Outcome Measures

    1. Surprise question [1 year]

      The ability of the cardiologist's response to the "surprise" question to predict adverse cardiac events within 1 year

    Secondary Outcome Measures

    1. Clinical characteristics and associations of the "good Fontan" [1 year]

      Clinical characteristics and associations of this group (the "good Fontan") are different compared to those that are in the "at-risk" category (all others that do not fit into the "good Fontan" category). Data measurements will include relevant clinical data available for each patient, including but not limited to data from cardiac surgeries, catheterizations, MRIs, echocardiograms, exercise stress tests, current medications, labs, and patient responses to questionnaires.

    2. Correlation between patient and provider assessments [1 year]

      There will be a positive correlation of the patient's own assessment of quality of life with the clinician-identified designation of a "good Fontan."

    3. Clinician factors associated with adverse events conversation with patients [1 year]

      Clinician factors (years of experience, primary subspecialty, gender, parenthood) are associated with beliefs in regard to appropriate timing to discuss potential long-term adverse events to Fontan patients.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Extracardiac or Lateral Funnel Fontan
    Exclusion Criteria:
    • Currently being evaluated for or listed for cardiac transplant

    • Underwent Fontan revision or conversion

    • Currently pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Boston Children's Hospital Boston Massachusetts United States 02115

    Sponsors and Collaborators

    • Boston Children's Hospital
    • New England Congenital Cardiology Association (NECCA)
    • Yale University
    • Dartmouth College
    • Connecticut Children's Medical Center
    • University of Vermont Children's Hospital
    • Child Heart Associates
    • Congenital Heart
    • University of Massachusetts, Worcester
    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: Rahul Rathod, MD, Boston Children's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Rahul Rathod, Cardiologist, Boston Children's Hospital
    ClinicalTrials.gov Identifier:
    NCT03470428
    Other Study ID Numbers:
    • IRB-P00024716
    First Posted:
    Mar 20, 2018
    Last Update Posted:
    Jul 28, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rahul Rathod, Cardiologist, Boston Children's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 28, 2021